Metraipolis › archive › dc_de2351fe4d29

Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database — Europe PMC PMID:41808830

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41808830
DOI
10.3389/fimmu.2026.1769109
License (as archived)
solo-consultazione
Archived
2026-10-08T04:41:16.368Z
SHA-256 of the archived text
92dccfbbc8dfc40c0ef24001f87ad93260c1e8f49b278d06bb2350527979b81b
Stable URL of this page
https://metraipolis.com/documento/dc_de2351fe4d29

How to cite

Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database — Europe PMC PMID:41808830 — Europe PMC (en), https://europepmc.org/article/MED/41808830 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_de2351fe4d29 (Metraipolis archive dc_de2351fe4d29, sha256 92dccfbbc8dfc40c0ef24001f87ad93260c1e8f49b278d06bb2350527979b81b)
BibTeX
@misc{dcde2351fe4d29,
  title = {Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database — Europe PMC PMID:41808830},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41808830},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_de2351fe4d29; sha256 92dccfbbc8dfc40c0ef24001f87ad93260c1e8f49b278d06bb2350527979b81b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41808830. Agents can read the archived copy with the MCP tool read_document.